Key points are not available for this paper at this time.
A new class of hybrid lanthanide nanoparticles has been demonstrated as synergistic contrast agents in T 1 / T 2 dual-weighted MRI and imaging-directed tumor diagnosis.
Yi et al. (2016) studied this question.